Introduction
Visceral leishmaniasis (VL) is caused by Leishmania donovani complex including L. donovani in the Indian subcontinent and Eastern Africa, L. infantum in Mediterranean area and Middle East and L. chagasi in Latin America. More than 65 countries are currently affected by VL and approximately 500,000 new human cases occur annually. Visceral leishmaniasis accounts for 75,000 deaths per year (1).
Leishmaniasis represents a major health problem in the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO) (2) . Cutaneous and visceral leishmaniasis are present in 14 of the 22 countries of the region. Zoonotic visceral leishmaniasis, caused by L. infantum, occurs in most countries of the region (2 A new focus of the disease has also been detected in Kohgiloyeh and Booyerahmad Province in southwest of the country. In a cross-sectional seroprevalence study, which was carried out in children in Booyerahmad district, anti-Leishmania antibodies were detected in 50 out of 1628 children (3.1%) by direct agglutination test (4) . The causative agent of VL in south and north of Iran is L. infantum with canine (dogs, foxes and jackal) as reservoirs. In some VL-endemic areas in Iran (e.g. Meshkin-Shahr) more than 10% of the reservoirs (dogs) have anti-Leishmania antibodies in their serum (3). Asymptomatic infected dogs play an important role in epidemiology of VL in endemic areas and are the source of infection for both human and animals (5) . L. tropica and L. major which are the causative agent of cutaneous leishmaniasis have been reported from VL patients in Iran (6) (7) (8) . The purposes of this retrospective study were to describe the characteristics of pediatric visceral leishmaniasis in southern Iran.
Patients and Methods
Hospital records of VL patients in university-affiliated hospitals in Shiraz, capital of Fars Province, were evaluated. Patients with positive IFA or positive parasitological tests (bone marrow aspiration) were considered as VL. All selected medical records were persistently reviewed and epidemiological data such as age, sex, place of residence and clinical data including signs and symptoms, physical examination, diagnostic tests, treatment and outcome of treatment were recorded. Collected data were analyzed using SPSS software.
Results
The total numbers of VL patients from 2001 to 2009 were 260 cases. From these, 156 (60%) were male and 104 (40%) were female. Their age ranged from one month to 36 years and the mean of age was 3.5 years. Ninety cases (34.6%) of patients were under 1 year and 77.7% of patients were under 5 years of age. The highest rate of disease was seen in 2 years old children. Table 1 shows the age distribution of patients. Table 2 shows the frequency of relapse in VL cases in different age group. Mortality rate in these patients were 6.2%. Most of death cases were from children under 1 year old. Death rate was more in male than female and this difference was statistically significant ( P < 0.05). The causes of death in these patients were reported to be secondary bacterial infection.
Discussion
Leishmaniases are endemic diseases in 88 countries in the world (1 ) and hepato-splenomegaly (42.2%). The highest sero-prevalence rate (1.55%) has been reported in children ≤ 5 years old (14) . Mediterranean type of the disease is present in Iran. In the current study, more than eighty percent of the cases were from children under 10 years old. Median age of VL patients was found to be 2 years. Same scenario is present in northwest of the country where 90% of VL cases are under 5 years old children (10) . The main causative agent of VL in south of Iran, as diagnosed by molecular methods and isoenzyme, are L. infantum. This is the causative agent of VL in northwest of the country as well (15) (16) .
Other species of Leishmania (L. major or L. tropica) have been reported to cause VL in Iran, but these are just a few case reports (7) (8) .
Dogs have been considered the main reservoir of L. infantum in Iran (2) . Although Leishmania infantum infected cats have been reported from Iran but their role in epidemiology of VL is still unclear (17) .
In the current study, most new cases of VL appeared from February to May. This is contributed to the incubation period of VL which ranged from 6 months to 6 weeks and the sand flies activation period which is from mid June through mid October (18) . The pentavalent antimonia compounds, such as sodium stibogluconate and meglumine antimoniate have been the mainstay of antileishmanial therapy for more than 40 years with response rate of about 90%. In contrast to African and Indian forms of VL, resistance to antimonial agents is rare in Mediterranean VL (15) . Although resistance to antimonial agents has been reported for cutaneous leishmaniasis in Iran, such data is not available for VL (19) . Most of patients in this study have been treated with glucantime and the second line drug for treatment has been amphotericin B. Unresponsiveness to the treatment (mainly with glucantime) was noticed in few cases since relapse has been found in 7.3% of cases. This in turn raises an alarm that drug resistance to glucantime might be present in VL patients in this area. Possible correlation between high relapse rate and too short treatment (21 days) needs further investigation. The mortality rate of VL in this study (6.2%) is equal to other reports in VL endemic areas. Bacterial super infection is one of the major complications in VL which leads to death in patients and this has been the case in our study as well (20) . Taken together, findings of the current retrospective study demonstrated that infantile VL is still prevalent in a few districts in southern Iran and its prevalence rate has not been significantly decreased over the last decade. Integration of VL surveillance system in primary care for children and timely treatment of cases could decrease the annual incidence of VL in the area, as this has been found to be effective in Meshkin-Shahr district, one of the focuses of VL in Iran (21) .
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